Sanofi-Aventis Deutschland GMBH v. Mylan Pharmaceuticals Inc.
Petition for certiorari denied on October 5, 2020
Issues: (1) Whether, in a pending case, a court can refuse to
entertain a constitutional, separation-of-powers challenge
based on an intervening change of law on the grounds
of forfeiture; and (2) whether the U.S. Court of Appeals for the Federal Circuit’s obviousness holding
is an unwarranted expansion of the Supreme Court’s decision
in KSR International Co. v. Teleflex Inc. and is inconsistent with the Patent Act.